SERAQUEST ANTI-THYROGLOBULIN— 510(k) K023592

Substantially Equivalent

Quest Intl., Inc.

FDA 510(k) clearance K023592 for SERAQUEST ANTI-THYROGLOBULIN, Substantially Equivalent on 2003-01-06. Applicant: Quest Intl., Inc..

Clearance details

Applicant: Quest Intl., Inc.
Product code: Code DDC
Advisory panel: Immunology
Date received: 2002-10-25
Decision date: 2003-01-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: North Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.